{"id":"W4417434215","doi":"10.51731/cjht.2025.1307","title":"Lazertinib and Amivantamab (Lazcluze and Rybrevant)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lung cancer; Drug; Clinical Practice; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002025106,0.0002944716,0.000625223,0.001865839,0.0002455101,0.001134417,0.0003951238,0.0005285466,0.00545576],"category_scores_gemma":[0.003395591,0.0001099655,0.001185681,0.001658449,0.0002568279,0.0006496056,0.000319269,0.0006662682,0.0009401849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002747522,"about_ca_system_score_gemma":0.003688703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01546332,"about_ca_topic_score_gemma":0.06860939,"domain_scores_codex":[0.9984598,0.0003943174,0.0001704876,0.00008016638,0.0008036859,0.00009162765],"domain_scores_gemma":[0.9985958,0.0004619838,0.0004029975,0.00002651517,0.00043741,0.00007540563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000800426,0.00005643187,0.001455883,0.009622844,0.0006026019,0.000112301,0.00005380224,0.0004381127,0.002122632,0.003760631,0.02986855,0.9511058],"study_design_scores_gemma":[0.0005724471,0.001246065,0.01596994,0.0092998,0.001776615,0.001243362,0.0001061189,0.0003802585,0.002768976,0.00117569,0.9654134,0.00004740485],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01056593,0.944864,0.000871252,0.003282247,0.0003229094,0.000234746,0.002035829,0.00008509482,0.03773788],"genre_scores_gemma":[0.1352112,0.835713,0.004120964,0.002686148,0.0003924706,0.0002907942,0.003519512,0.00002945284,0.01803645],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01546332,"threshold_uncertainty_score":0.03074664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01261210228399007,"score_gpt":0.3396914984257826,"score_spread":0.3270793961417925,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}